Cargando…
POS-064 NEPHROTOXICITY OF LIPOSOMAL AMPHOTERICIN B IN PATIENTS WITH RHINO-ORBITO-CEREBRAL MUCORMYCOSIS(ROCM) IN POST COVID PATIENTS -WHAT WE NEED TO KNOW?
Autor principal: | Kotha, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475076/ http://dx.doi.org/10.1016/j.ekir.2022.07.081 |
Ejemplares similares
-
Rhino-Orbito-Cerebral Mucormycosis (ROCM) in COVID-19 Patients
por: Sharma, Vagisha, et al.
Publicado: (2023) -
Our children are at risk of COVID-19- associated rhino-orbito-cerebral mucormycosis (ROCM)
por: Saied, AbdulRahman A., et al.
Publicado: (2021) -
Tracing, Tracking and Treating COVID-19 Associated Rhino-Orbito Cerebral Mucormycosis (ROCM)
por: Bidkar, Vijay, et al.
Publicado: (2022) -
Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B
por: Safi, Mustafa, et al.
Publicado: (2020) -
Rhino-orbito-cerebral mucormycosis (ROCM) with internal carotid artery stenosis in a diabetic patient with caries tooth and oroantral fistula
por: Manjunath, Kataveeranahally Shekar, et al.
Publicado: (2016)